Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2000
03/15/2000EP0984788A1 Pharmaceutical compostions of peptides having low solubility in physiological medium
03/15/2000EP0984784A2 Anti-cancer products for treating cystic fibrosis
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0859606A4 Buccal delivery of glucagon-like insulinotropic peptides
03/15/2000EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
03/15/2000EP0753063B1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
03/15/2000EP0739204A4 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
03/15/2000EP0723453B1 Method of treating reproductive disorders
03/15/2000EP0667781B1 Peptide diagnostics and therapeutics for spondyloarthropathies
03/15/2000EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
03/15/2000EP0656008B1 Thrombin receptor antagonists
03/15/2000EP0653939B1 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
03/15/2000EP0649468B1 Soluble cr1 derivatives
03/15/2000EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/15/2000EP0610286B1 Recombinant immunotoxins
03/15/2000EP0604433B1 Composition comprising glutathione enhancers and vitamines for the treatment of aids, cancer and diabetes
03/15/2000EP0589937B1 Use of 4-(4-chlorophenyl-sulphonylcarbamoyl) benzoyl-l-valyl-l-proline 1(rs)-(1-trifluoroacetyl-2-methylpropyl) amide for the preparation of a medicament for the treatment of vascular diseases
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000EP0549702B1 Use of recombinant colony stimulating factor-1
03/15/2000EP0541726B1 Growth factor compositions, preparation and use
03/15/2000EP0506785B1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247568A Fibroblast growth factor homologs
03/15/2000CN1247566A Novel peptide, novel DNA, and novel antibody
03/15/2000CN1247543A Cyclic peptide derivatives
03/15/2000CN1247542A Serine protease inhibitors
03/15/2000CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
03/15/2000CN1247472A Treatment of lupus nephritis with anti-CD40L compounds
03/15/2000CN1247060A Novel medicinal compsns. containing cyclosporin
03/15/2000CN1247036A Colostrum SOD nutrient
03/15/2000CN1050301C Implant compsns. containing biologically active protein, peptide or polypeptide
03/15/2000CN1050285C Method for prepn. of pressurised aerosol compositions
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037463 Ribozyme that cleaves mutant messenger ribonucleic acids associated with cancer; anticarcinogenic agents; antitumor agents
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037449 Polypeptide associated with bone and dentin tissues; for osteoporosis and bone cancer diagnosis; antiinflammatory agents
03/14/2000US6037448 Chimeric viral protein with human lymphocyte determinant; for vaccine development against infection
03/14/2000US6037447 Glycopeptide compounds
03/14/2000US6037446 Gestational agents for controlling cell proliferation
03/14/2000US6037376 Methods for therapy of cancer
03/14/2000US6037370 Methods and compositions for stimulating neurite growth
03/14/2000US6037363 Respiratory system disorders, cystic fibrosis
03/14/2000US6037329 Compositions containing nucleic acids and ligands for therapeutic treatment
03/14/2000US6037325 Certain substituted oxadiazole, thiadiazole and triazole peptoids used effectively to prevent, alleviate or otherwise treat disease states characterized by the degradation of connective tissue such as respiratory system disorders and
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/14/2000US6037323 Peptides and peptide analogues that mimic the structural and pharmacological properties of human apoa-i; treating disorders associated with dyslipoproteinemia, including hypercholesterolemia, cardiovascular disease, atherosclerosis,
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6037320 Neurotrophic factor (NT-4)
03/14/2000US6037176 Nucleotide sequences that are suppressors of human cell adhesion molecule gene expression; anticarcinogenic agents, antiinflammatory agents
03/14/2000US6037173 Nucleic acid molecule that codes a thyroid receptor binding protein; for diagnosis and treatment of diseases associated with defects in the function of thyroid binding protein; for detection of mudulators of protein function
03/14/2000US6037165 Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby
03/14/2000US6037164 Human parvulin-like protein
03/14/2000US6037160 Nucleotide sequence that codes for an insect hydrolytic enzyme; to reduce insect parasitic infestation in animals; for development of vaccines to prevent parasitic infestation in animals
03/14/2000US6037157 Method for improving pharmacokinetics
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis
03/14/2000US6037142 Nucleotide sequences used to suppress cytosolic human gene product associated with gene transcription; antiinflammatory agents; anticarcinogenic agents
03/14/2000US6037135 Methods for making HLA binding peptides and their uses
03/14/2000US6037132 Method for detecting HTRAN polynucleotides
03/14/2000US6037131 Screening candidate compound for ability to alter transcription from gene promoter; providing recombinant cell, contacting cell with candidate compound, detecting expression pattern of reporter gene in the presence candidate compound
03/14/2000US6037125 Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
03/14/2000US6037121 DNA sequence encoding a tumor suppressor gene
03/14/2000US6036978 Antiinflammatory agents for gastrointestinal disorders
03/14/2000US6036972 Method of treating dilated cardiomyopathy
03/14/2000US6036961 Immunogenic antigens of giardia cultures in bile
03/14/2000US6036959 HCMV/HSV fusion glycoproteins
03/14/2000US6036958 Tsetse thrombin inhibitor
03/14/2000US6036957 Immunology suppression with cd4 and t-cells reactive with mylin protein
03/14/2000US6036956 Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease
03/14/2000US6036955 Antitumor agents
03/14/2000US6036954 Polypeptides with sequence
03/14/2000US6036949 Humans and administering interferon buccally, sublingually by mouth as long as the patient is not infected with hepatitis c
03/14/2000US6036948 Polyaspartamide derivatives as adsordents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals
03/14/2000CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
03/14/2000CA2132424C Antisense oligonucleotide inhibition of papillomavirus
03/14/2000CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/14/2000CA2071205C Cell surface antigen associated with cellular apoptosis
03/14/2000CA2013188C Preservative system for ophthalmic formulations
03/14/2000CA2010778C Bioactive agents, compositions and materials comprising said bioactive agents
03/14/2000CA2010177C Purified mite allergen
03/14/2000CA2006969C Polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide
03/14/2000CA1340926C Human rhinovirus peptides
03/09/2000WO2000012762A1 A novel protein related to melanoma-inhibiting protein and uses thereof
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012740A2 ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012726A2 Rationally designed heparinases derived from heparinase i and ii
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012718A1 Superoxide dismutase as a vaccine antigen
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012711A2 Human membrane channel proteins
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012707A1 14926 receptor, a novel g-protein coupled receptor
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012701A1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
1 ... 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 ... 3163